Anyone considering IV therapy should undergo screening for conditions like glucose 6 phosphate dehydrogenase (G6PD) deficiency, kidney problems, and iron overload
Corbin KD, Carnero EA, Allerton TD, Tillner J, Bock CP, Luyet PP, et al
Studies from the National Institute of Environmental Health Sciences confirmed that individuals with genetic polymorphisms reducing glutathione S-transferase activity (GSTM1-null and GSTT1-null genotypes, present in 4060% of some populations) showed increased susceptibility to environmental toxins and certain cancers
Geiser JS, Heathman MA, Cui X, Martin J, Loghin C, Chien JY, de la Pea A (2016) Clinical pharmacokinetics of dulaglutide in patients with type 2 diabetes: analyses of data from clinical trials
The feeling isn't "all in your head." It's a real, physical signal from your body that something is out of balance